PCM
SNY icon

Prelude Capital Management’s Sanofi SNY Stock Holding History

Prelude Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,500
Closed -$109K – 2231
2020
Q1 		$109K Buy
+2,500
New +$120K 0.01% 573
2015
Q2 		– Sell
-1,000
Closed -$49K – 2010
2015
Q1 		$49K Buy
+1,000
New +$47.8K 0.01% 1293

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Prelude Capital Management's SNY Position: Q3 2020 in Review

Prelude Capital Management sold out of Sanofi (SNY) in Q3 2020, closing a stake of 27,586 shares — an estimated $1.41M sold.

Prelude Capital Management first reported a position in SNY in Q4 2014 and held it in 4 quarters. The position peaked at $1.41M in Q2 2020. 574 funds tracked by Wall St. Rank hold SNY as of Q3 2020.

  • Prelude Capital Management reported no remaining Sanofi position as of Q3 2020 after selling out during the quarter.
  • Prelude Capital Management sold 27,586 Sanofi shares in Q3 2020, an estimated $1.41M.
  • Prelude Capital Management first reported a position in Sanofi in Q4 2014 and held it in 4 quarters.
  • Prelude Capital Management's Sanofi position peaked at $1.41M in Q2 2020.
  • 574 funds tracked by Wall St. Rank held Sanofi as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.